WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic ...

The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.

The ECDC says the region could still meet its testing targets for HIV, but that it will be harder to improve detection for ...

Enanta Pharmaceuticals recorded a narrower loss as sales rose in its fiscal fourth quarter driven by higher sales of a hepatitis C virus treatment.

Atea Pharmaceuticals, Inc. ( AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Jordan Feld Anthony Martinez Nancy Reau Eric ...

Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ETBOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Atea ...

The office surgery center lacked “a handwashing station with the capabilities to sterilize the surgical team members’ hands..

Rowen (not his real name) decided to create a Facebook group dedicated to raising public awareness about liver-related illnesses. Diagnosed with hepatitis B about eight years ago and now in the ...

Until recently, it was not uncommon for Dr. Jeannie Kelly, a high risk obstetrician at Washington University School of Medicine in St. Louis, to diagnose a pregnant patient with Hepatitis C, then ...

WASHINGTON -- Assessing sustained virological response (SVR) to hepatitis C virus (HCV) therapy at 4 weeks after treatment ...

Get the latest on Atea Pharmaceuticals’ Q3 2025 earnings, HCV Phase III progress, hepatitis E pipeline expansion, and key financial updates.